PolyNovo Past Earnings Performance
Past criteria checks 3/6
PolyNovo has been growing earnings at an average annual rate of 29.2%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 37.1% per year. PolyNovo's return on equity is 7.3%, and it has net margins of 5.1%.
Key information
29.2%
Earnings growth rate
29.2%
EPS growth rate
Medical Equipment Industry Growth | 5.8% |
Revenue growth rate | 37.1% |
Return on equity | 7.3% |
Net Margin | 5.1% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?
Oct 10PolyNovo (ASX:PNV) Is Experiencing Growth In Returns On Capital
Aug 28PolyNovo Limited's (ASX:PNV) P/S Is On The Mark
Aug 06PolyNovo Limited's (ASX:PNV) P/S Is On The Mark
May 08When Should You Buy PolyNovo Limited (ASX:PNV)?
Feb 28Why Investors Shouldn't Be Surprised By PolyNovo Limited's (ASX:PNV) P/S
Feb 02PolyNovo Limited (ASX:PNV) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 08Health Check: How Prudently Does PolyNovo (ASX:PNV) Use Debt?
Sep 22When Should You Buy PolyNovo Limited (ASX:PNV)?
Jun 26Are Investors Undervaluing PolyNovo Limited (ASX:PNV) By 29%?
May 30Shareholders Should Be Pleased With PolyNovo Limited's (ASX:PNV) Price
Apr 18Is It Too Late To Consider Buying PolyNovo Limited (ASX:PNV)?
Mar 23Is PolyNovo Limited (ASX:PNV) Worth AU$2.6 Based On Its Intrinsic Value?
Feb 05Returns At PolyNovo (ASX:PNV) Are On The Way Up
Nov 16PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price
Nov 01What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?
Jul 29PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital
Jun 15Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)
May 16We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt
Apr 28There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital
Mar 07Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?
Dec 13PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why
Oct 19Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?
May 08News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat
Feb 27Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts
Feb 25Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?
Feb 17Revenue & Expenses Breakdown
How PolyNovo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 103 | 5 | 81 | 0 |
31 Mar 24 | 93 | 3 | 74 | 0 |
31 Dec 23 | 83 | 2 | 69 | 0 |
30 Sep 23 | 75 | -2 | 63 | 0 |
30 Jun 23 | 66 | -5 | 55 | 0 |
31 Mar 23 | 59 | -6 | 51 | 0 |
31 Dec 22 | 53 | -7 | 47 | 0 |
30 Sep 22 | 48 | -4 | 39 | 0 |
30 Jun 22 | 42 | -1 | 32 | 0 |
31 Mar 22 | 38 | 0 | 29 | 0 |
31 Dec 21 | 35 | 1 | 26 | 0 |
30 Sep 21 | 32 | -2 | 27 | 0 |
30 Jun 21 | 29 | -5 | 27 | 0 |
31 Mar 21 | 27 | -5 | 26 | 0 |
31 Dec 20 | 25 | -5 | 25 | 0 |
30 Sep 20 | 24 | -5 | 23 | 0 |
30 Jun 20 | 22 | -4 | 21 | 0 |
31 Mar 20 | 20 | -4 | 19 | 0 |
31 Dec 19 | 18 | -4 | 17 | 0 |
30 Sep 19 | 16 | -3 | 15 | 0 |
30 Jun 19 | 14 | -3 | 12 | 0 |
31 Mar 19 | 12 | -4 | 11 | 0 |
31 Dec 18 | 9 | -5 | 9 | 0 |
30 Sep 18 | 8 | -5 | 9 | 0 |
30 Jun 18 | 7 | -6 | 8 | 0 |
31 Mar 18 | 6 | -6 | 8 | 0 |
31 Dec 17 | 5 | -6 | 8 | 0 |
30 Sep 17 | 4 | -6 | 8 | 0 |
30 Jun 17 | 4 | -5 | 7 | 0 |
31 Mar 17 | 4 | -4 | 6 | 0 |
31 Dec 16 | 5 | -3 | 5 | 0 |
30 Sep 16 | 4 | -3 | 5 | 0 |
30 Jun 16 | 3 | -3 | 5 | 0 |
31 Mar 16 | 2 | -3 | 4 | 0 |
31 Dec 15 | 0 | -2 | 4 | 0 |
30 Sep 15 | 0 | -2 | 3 | 0 |
30 Jun 15 | 0 | -1 | 3 | 0 |
31 Mar 15 | 0 | -2 | 3 | 0 |
31 Dec 14 | 0 | -3 | 3 | 0 |
30 Sep 14 | 0 | -3 | 3 | 0 |
30 Jun 14 | 0 | -3 | 3 | 0 |
31 Mar 14 | 0 | -2 | 3 | 0 |
Quality Earnings: PNV has high quality earnings.
Growing Profit Margin: PNV became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PNV has become profitable over the past 5 years, growing earnings by 29.2% per year.
Accelerating Growth: PNV has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PNV has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: PNV's Return on Equity (7.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/04 04:27 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PolyNovo Limited is covered by 10 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Hester | Bell Potter |
Lyanne Harrison | BofA Global Research |
Andrew Paine | CLSA |